$Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease$

Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease

We report on a 64-year-old woman with multirefractory flare of adult-onset Still’s disease successfully treated with six-month course of add-on anti-interleukin 6 receptor antibody, tocilizumab. Before administration of tocilizumab, the combination therapy with 80 mg/day of prednisolone and cyclospo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical rheumatology 2013-03, Vol.32 (Suppl 1), p.103-106
Hauptverfasser:	Naniwa, Taio, Ito, Rei, Watanabe, Maiko, Hayami, Yoshihito, Maeda, Shinji, Sasaki, Kaneshige, Iwagaitsu, Shiho
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - therapeutic use Case Report Case reports Cyclosporine - therapeutic use Cyclosporins Dose-Response Relationship, Drug Drug Resistance, Multiple - drug effects Drug Therapy, Combination Female Humans Immunoglobulins, Intravenous - therapeutic use Immunologic Factors - therapeutic use Interleukin 6 Intravenous administration Medicine Medicine & Public Health Methylprednisolone Methylprednisolone - therapeutic use Middle Aged Monoclonal antibodies Prednisolone Prednisolone - therapeutic use Pulse Therapy, Drug Recurrence Remission Remission Induction Rheumatology Still's Disease, Adult-Onset - drug therapy Tacrolimus Tacrolimus - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!